Suppr超能文献

头孢克洛对流感嗜血杆菌疗效的分子基础

Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.

作者信息

Picard M, Malouin F

机构信息

Département de Microbiologie and Laboratorie, Centre Hospitalier de l'Université Laval, Québec, Canada.

出版信息

Antimicrob Agents Chemother. 1992 Nov;36(11):2569-72. doi: 10.1128/AAC.36.11.2569.

Abstract

Cefaclor sustained its inhibitory activity against a beta-lactamase-producing strain of Haemophilus influenzae. Although a relatively high permeability coefficient was calculated for ampicillin compared with that calculated for cefaclor, the resulting periplasmic concentration of cefaclor was 5.7 times that of ampicillin. The efficacy of cefaclor may be due to its higher beta-lactamase resistance, which allows it to achieve a greater periplasmic concentration and adequate binding to crucial penicillin-binding proteins.

摘要

头孢克洛对产β-内酰胺酶的流感嗜血杆菌持续保持抑制活性。虽然计算得出氨苄西林的通透性系数相对于头孢克洛较高,但头孢克洛在周质中的浓度是氨苄西林的5.7倍。头孢克洛的疗效可能归因于其更高的β-内酰胺酶耐药性,这使其能够在周质中达到更高的浓度,并与关键的青霉素结合蛋白充分结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8c8/284379/a152d6ccdec0/aac00375-0244-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验